Brief: Renovorx Announces Pricing Of Initial Public Offering
26/08/2021 02:38
RenovoRx Inc RNXT.O :
* RENOVORX ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
* PRICING OF ITS UNDERWRITTEN INITIAL PUBLIC OFFERING OF
1,850,000
UNITS AT A PUBLIC OFFERING PRICE PER UNIT OF $9.00
Source text for Eikon: ID:nPn65M8tVa
Further company coverage: RNXT.O
Recent news on RenovoRx
See all newsBrief: RenovoRx Gets FDA Orphan Drug Designation For Oxaliplatin To Treat Pancreatic Cancer
RenovoRx Q1 revenue rises as number of active cancer centers increase
RenovoRx 2025 net loss widens on higher operating expenses
Brief: RenovoRx FY Net Income USD -11.168 Million
U.S. STOCKS ON THE MOVE-Vertex Pharma, U.S. Energy Corp, SoFi Technologies